Pacific Biosciences of California, Inc.
Hedge Funds Holdings
Last updated:
Pacific Biosciences of California, Inc.‘s stocks are currently a part of 232 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 221.50M shares of Pacific Biosciences of California, Inc.. Compared to the previous quarter, the number grew by 7.88% or 16.18M shares more. As for the holding position changes, 38.79% (90) of current hedge fund investors increased the number of shares held, 27.59% (64) of current holders sold a part of the shares held, and 21.55% (50) closed the holdings completely. 41 hedge funds are new holders of Pacific Biosciences of California, Inc. stock in Q1 2022, it is 17.67% of total holders.
Hedge funds holding Pacific Biosciences of California (Q2 2017 – Q1 2022)
| Q2 2017 | 105 |
|---|---|
| Q3 2017 | 95 |
| Q4 2017 | 104 |
| Q1 2018 | 98 |
| Q2 2018 | 97 |
| Q3 2018 | 116 |
| Q4 2018 | 153 |
| Q1 2019 | 158 |
| Q2 2019 | 147 |
| Q3 2019 | 145 |
| Q4 2019 | 138 |
| Q1 2020 | 129 |
| Q2 2020 | 146 |
| Q3 2020 | 172 |
| Q4 2020 | 204 |
| Q1 2021 | 250 |
| Q2 2021 | 250 |
| Q3 2021 | 235 |
| Q4 2021 | 246 |
| Q1 2022 | 232 |
Hedge funds changes in Pacific Biosciences of California positions (Q2 2017 – Q1 2022)
| Q2 2017 | 15 | 34 | 38 | 14 | 4 |
|---|---|---|---|---|---|
| Q3 2017 | 14 | 42 | 19 | 23 | -3 |
| Q4 2017 | 23 | 32 | 31 | 14 | 4 |
| Q1 2018 | 10 | 49 | 19 | 16 | 4 |
| Q2 2018 | 8 | 38 | 26 | 9 | 16 |
| Q3 2018 | 27 | 36 | 29 | 8 | 16 |
| Q4 2018 | 70 | 45 | 26 | 33 | -21 |
| Q1 2019 | 28 | 65 | 41 | 22 | 2 |
| Q2 2019 | 17 | 64 | 41 | 24 | 1 |
| Q3 2019 | 21 | 52 | 49 | 23 | 0 |
| Q4 2019 | 24 | 54 | 39 | 31 | -10 |
| Q1 2020 | 20 | 49 | 44 | 29 | -13 |
| Q2 2020 | 33 | 47 | 38 | 16 | 12 |
| Q3 2020 | 54 | 62 | 41 | 28 | -13 |
| Q4 2020 | 69 | 66 | 54 | 36 | -21 |
| Q1 2021 | 75 | 77 | 77 | 26 | -5 |
| Q2 2021 | 49 | 91 | 68 | 47 | -5 |
| Q3 2021 | 25 | 96 | 73 | 38 | 3 |
| Q4 2021 | 48 | 85 | 77 | 37 | -1 |
| Q1 2022 | 41 | 90 | 64 | 50 | -13 |
Hedge funds changes in Pacific Biosciences of California stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 4,000 | 731,000 |
|---|---|---|
| Q3 2017 | 115,000 | 1,953,000 |
| Q4 2017 | 26,000 | 1,061,000 |
| Q1 2018 | 57,000 | 409,000 |
| Q2 2018 | 182,000 | 495,000 |
| Q3 2018 | 248,000 | 1,040,000 |
| Q4 2018 | 6,329,000 | 4,624,000 |
| Q1 2019 | 313,000 | 4,358,000 |
| Q2 2019 | 790,000 | 1,220,000 |
| Q3 2019 | 294,000 | 1,559,000 |
| Q4 2019 | 511,000 | 1,447,000 |
| Q1 2020 | 826,000 | 1,149,000 |
| Q2 2020 | 968,000 | 545,000 |
| Q3 2020 | 4,734,000 | 751,000 |
| Q4 2020 | 29,996,000 | 40,220,000 |
| Q1 2021 | 43,699,302 | 29,605,706 |
| Q2 2021 | 26,709,536 | 35,665,543 |
| Q3 2021 | 28,242,900 | 47,476,315 |
| Q4 2021 | 18,145,314 | 20,444,946 |
| Q1 2022 | 13,540,000 | 15,476,000 |